Business Segments ICON Public Limited Company

Equities

Real-time Estimate Cboe BZX Other stock markets 10:42:49 2025-01-14 am EST			5-day change	1st Jan Change
207.76 ^USD	-4.70%		-7.29%	-1.60%

02:37pm	ICON Reaffirms 2024 Outlook, Provides 2025 Guidance; Shares Down Pre-Bell	MT
Jan. 08	Icon plc Releases the Findings of A Survey of over 120 Biomarkers and Pharma Professionals Developing Treatments for Neurodegenerative Disorders	CI

See more © MarketScreener.com

See more © MarketScreener.com

Breakdown by Business Segment (USD)

Fiscal Period: December	2019	2020	2021	2022	2023
Life Sciences Tools and Services
Medical Labs & Research	2.81B	2.8B	5.48B	7.74B	8.12B
Total Assets	2.91B	3.44B	17.39B	17.19B	16.99B
Interest Expense	-13.28M	-13.02M	-182M	-230M	-337M
Income Tax Expense	51.13M	47.88M	41.33M	59.41M	11.75M
CAPEX	-50.64M	-51.06M	-93.75M	-142M	-141M
EBT	427M	381M	197M	568M	624M
D&A	91.92M	94.61M	315M	570M	586M
Operating Income	433M	392M	379M	795M	956M
Net Income	374M	332M	153M	505M	612M

Geographical breakdown of sales (USD)

Fiscal Period: December	2019	2020	2021	2022	2023
United States (U.S.)	892M	926M	2.58B	3.57B	3.28B
Total Assets	755M	909M	240M	213M	159M
Income Tax Expense	1.57M	7.6M	-	-	-
D&A	33.92M	36.06M	-	-	-
CAPEX	-18.64M	-14.35M	-	-	-
Operating Income	60.27M	57.68M	232M	255M	310M
Ireland	1.25B	1.18B	1.37B	1.98B	2.38B
Total Assets	1.32B	1.68B	118M	143M	199M
Income Tax Expense	38.79M	30.62M	-	-	-
D&A	30.64M	33.52M	-	-	-
CAPEX	-32.53M	-29.31M	-	-	-
Operating Income	314M	295M	162M	218M	432M
Rest of Europe	389M	417M	1.18B	1.62B	1.57B
Total Assets	661M	671M	121M	99.72M	94.05M
Income Tax Expense	4.23M	4.61M	-	-	-
D&A	14.37M	18.57M	-	-	-
CAPEX	-13.97M	-9.3M	-	-	-
Operating Income	38M	35.4M	183M	254M	153M
Rest of world	272M	274M	358M	564M	884M
Total Assets	168M	179M	55.31M	48.1M	49.18M
Income Tax Expense	6.54M	5.05M	-	-	-
D&A	13M	11.87M	-	-	-
CAPEX	-15.01M	-10.2M	-	-	-
Operating Income	20.85M	21.15M	30.63M	68.5M	60.33M